UPDATE 1-China rejects patent linked to Gilead hepatitis C drug
June 19, 2015 at 04:24 AM EDT
* Sovaldi controversial due to its high cost of $1,000 per pill (Recasts and writes through with details of the drug)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.